QLT names Robert Butchofsky president, CEO

By Lisa Kerner

Erie, Pa., Feb. 27 - QLT Inc.'s board of directors said it has appointed Robert Butchofsky as president and chief executive officer and as a director of the board.

The board also named C. Boyd Clarke as the new chairman. Both of these appointments are effective immediately.

Past chairman E. Duff Scott will remain as a director of the board, according to a company news release.

Butchofsky was appointed to acting CEO in September. He joined QLT in 1998 and was named vice president, marketing and sales planning in September 2001.

Clarke has been a director of QLT since 2003 and is currently chairman and a director of Neose Technologies Inc., a publicly listed biotechnology company focused on the development of protein therapeutics. He was president and CEO of Neose from 2002 to 2006.

QLT is a global biopharmaceutical company specializing in developing treatments for eye diseases as well as dermatological and urological conditions. The company is based in Vancouver, B.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.